Actually, we have previously shown the potential of OBP-702 to overcome immune suppression by inducing apoptosis and autophagy on cancer-associated fibroblasts via p53 overexpression [38]; however, its effects on long-term anti-tumor immunity are still unclear. The gene discussed is TP53; the disease is cancer.